Clinical Trial Update: A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders

View source ↗

Summary

This is a single-arm safety study evaluating transplantation using umbilical cord blood and placental-derived stem cells from partially matched related donors i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Non-malignant Hematologic Disorders

Snippet

Sponsor: Celgene Corporation | Conditions: Hematologic Malignancies | Status: UNKNOWN